CD28 and chronic kidney disease: There was a significant trend that as CKD stages increased, percentages of CD4+CD127+ cells, CD8+ TNAIVE cells, and CD8+CD127+ cells decreased while percentages of effector CD8+ TE cells, CD8+CD28+ cells, and CD8+CD57+ cells increased (Table 3).